Pyridoxine effect on synthesis rate of serotonin in the monkey brain measured with positron emission tomography
- 1 June 1995
- journal article
- research article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 102 (2) , 91-97
- https://doi.org/10.1007/bf01276505
Abstract
The influence of the co-factor pyridoxine, vitamin B6, on the activity of aromatic amino acid decarboxylase enzyme was studied by positron emission tomography, PET in the brain of the Rhesus monkey using the precursor for serotonin synthesis 5-hydroxy-L-tryptophan (5-HTP) radiola-belled with11C in the β-position. The rate constant for the formation of serotonin in the corpus striatum was calculated using a two tissue compartment model with reference area in the brain. In baseline investigations, the mean rate constants (±S.D:) for selective utilization of [11C]5-HTP to form [11C]serotonin in the corpus striatum was 0.0080 ± 0.0011 min−1. Pretreatment with intravenous pyridoxine hydrochloride 10 mg/kg bodyweight before doing a second PET study resulted in an enhanced rate constant by a mean of 20%. The rate increase was statistically significant. The increase varied considerably in different monkeys from no effect to more than 60%. The effect of pyridoxine on aromatic amino acid decarboxylase activity supported a regulatory role of pyridoxine on the synthesis of neurotransmitter in vivo, and may be of importance in diseases with deficiencies in neurotransmitter function.Keywords
This publication has 26 references indexed in Scilit:
- A DOUBLE BLIND STUDY OF VITAMIN B6 IN DOWN'S SYNDROME INFANTS. PART 2-CORTICAL AUDITORY EVOKED POTENTIALSJournal of Intellectual Disability Research, 2008
- Positron emission tomographic studies on aromatic L-amino acid decarboxylase activity in vivo for L-dopa and 5-hydroxy-L-tryptophan in the monkey brainJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1993
- Monoamine metabolism in human prefrontal cortex and basal ganglia. Pet studies using [β‐11C] l–5‐hydroxytryptophan and [β‐11C] L‐dopa in healthy volunteers and patients with unipolar major depressionDepression, 1993
- Estimation of regional cerebral utilization of [11C]-L-3, 4-dihydroxy-phenylalanine (DOPA) in the primate by positron emission tomographyActa Neurologica Scandinavica, 1992
- Cerebral uptake and utilization of therapeutic [β-11C]-L-DOPA in Parkinson's disease measured by positron emission tomography. Relations to motor responseActa Neurologica Scandinavica, 1992
- Brain kinetics of 11 C-labelled L-tryptophan and 5-hydroxy-L-tryptophan in the Rhesus monkeyJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1992
- Neuronal DOPA DecarboxylaseaAnnals of the New York Academy of Sciences, 1990
- Enhancement of Dopamine Release In Vivo from the Rat Striatum by Dialytic Perfusion of 6R‐l‐erythro‐5,6,7,8‐TetrahydrobiopterinJournal of Neurochemistry, 1990
- Sympathetic stimulation and hypertension in the pyridoxine-deficient adult rat.Hypertension, 1988
- EFFECT OF PYRIDOXINE HYDROCHLORIDE (VITAMIN B6) UPON DEPRESSION ASSOCIATED WITH ORAL CONTRACEPTIONThe Lancet, 1973